7-Oct-2008

Subscription Info | Institutional Access | Browse the Faculties | Free Trial | Take a Tour | Top 10s | Advanced Search | Faculty Member List | About

Search   All F1000 MedicineRespiratory Diso...         Browse ALL OF MEDICINE Respiratory Disorders Asthma & Allergic Rhinitis COPD & Allied Disorders Environmental & Occupational Lung Diseases Extrapulmonary Disorders & Therapeutic Interventions Interstitial Lung Diseases Lung Cancer Pulmonary Vascular Diseases Respiratory Infections Respiratory Pediatrics Sleep & Ventilation Disorders Related Sections Respiratory Problems in Critical Care selected for My F1000 Medicine

Browse > Respiratory Disorders Current Top 10 by F1000 Factor / All Time Top 10 by F1000 Factor / Most viewed (from all journals) / Most viewed (from specialty journals) / Hidden jewels Page 1 of 40. Select Page: 1 2 3 4 5 6 7 8 9 10 >> Display 10 / 20 / 50 papers per page printer friendly  10 per page20 per page50 per pageany datepast 7dpast 14dpast 30dpast 60dpast 90dpast 180dpast 1ypast 2ypast 5yall papershypothesesnew findingsconfirmationstech advancescontroversialrefutationdissentingnew on F1000newly evaluatedF1000 factormost evaluations this pageselected articlesto EndNoteRef. ManagerRefWorksBibtexProCite email [Help] Must Read F1000 Factor 6.0 Hypothesis New Finding Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis. Hofmann S, Franke A, …, Rosenstiel P, Schreiber S Nat Genet 2008 Aug 10 40 [abstract on PubMed] [related articles] [full text] Selected by | Anders Eklund Evaluated 3 Oct 2008 Recommended F1000 Factor 3.0 Confirmation Use of B-type natriuretic peptide in the risk stratification of community-acquired pneumonia. Christ-Crain M, Breidthardt T, …, Mueller B, Mueller C J Intern Med 2008 Aug 264(2):166-76 [abstract on PubMed] [related articles] [full text] [order article] Selected by | Charles Feldman with Erica Shaddock Evaluated 3 Oct 2008 Recommended F1000 Factor 3.0 Confirmation Aspergillus fumigatus-induced IL-8 synthesis by respiratory epithelial cells is controlled by the PI3 kinase, p38 MAPK and ERK1/2 pathways and not by the TLR-MYD88 pathway. Balloy V, Sallenave JM, …, Si-Tahar M, Chignard M J Biol Chem 2008 Aug 14 [abstract on PubMed] [related articles] [FREE full text] Selected by | Cornelia Lass-Floerl with Susanne Perkhofer Evaluated 2 Oct 2008 Must Read F1000 Factor 6.0 Hypothesis New Finding The effects of leptin on airway smooth muscle responses. Nair P, Radford K, …, Peters-Golden M, Cox PG Am J Respir Cell Mol Biol 2008 Oct 39(4):475-81 [abstract on PubMed] [related articles] [full text] [order article] Selected by | Andreina Bruno Evaluated 1 Oct 2008 Recommended F1000 Factor 3.0 Confirmation Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Yu X, Tsibane T, …, Basler CF, Crowe JE Nature 2008 Sep 25 455(7212):532-6 [abstract on PubMed] [related articles] [full text] [order article] Selected by | David A. Groneberg with David Quarcoo Evaluated 30 Sep 2008 Recommended F1000 Factor 3.0 Confirmation Tuberculosis in Africa: learning from pathogenesis for biomarker identification. Kaufmann SH, Parida SK Cell Host Microbe 2008 Sep 11 4(3):219-28 [abstract on PubMed] [related articles] [full text] [order article] Selected by | James Tartaglia with Robin Harkness Evaluated 30 Sep 2008 Recommended F1000 Factor 3.0 Confirmation Lung cancer in octogenarians: factors affecting long-term survival following resection. Dominguez-Ventura A, Cassivi SD, …, Pairolero PC, Deschamps C Eur J Cardiothorac Surg 2007 Aug 32(2):370-4 [abstract on PubMed] [related articles] [FREE full text] Selected by | Martine Extermann Evaluated 29 Sep 2008 Recommended F1000 Factor 3.0 Confirmation SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Charles PG, Wolfe R, …, Australian Community-Acquired Pneumonia Study Collaboration, Grayson ML Clin Infect Dis 2008 Aug 1 47(3):375-84 [abstract on PubMed] [related articles] [full text] [order article] Selected by | Mark Metersky with Jafar Abunasser Evaluated 29 Sep 2008 Recommended F1000 Factor 3.0 New Finding Controversial Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer. Früh M, Rolland E, …, Spiro S, Shepherd FA J Clin Oncol 2008 Jul 20 26(21):3573-81 [abstract on PubMed] [related articles] [full text] [order article] Selected by | Jack West Evaluated 26 Sep 2008 Recommended F1000 Factor 3.0 Changes Clinical Practice Confirmation New Finding Lung insufflation capacity in neuromuscular disease. Bach JR, Mahajan K, …, Goncalves M, Komaroff E Am J Phys Med Rehabil 2008 Sep 87(9):720-5 [abstract on PubMed] [related articles] [full text] [order article] Selected by | Anastassios Koumbourlis Evaluated 26 Sep 2008 top of page Page 1 of 40. Select Page: 1 2 3 4 5 6 7 8 9 10 >> Display 10 / 20 / 50 papers per page

---

© 2008 Medicine Reports Ltd unless otherwise stated < info@f1000.com >   Terms and conditions   Legal info